FAQs
What triggers melanocyte destruction in vitiligo?
Melanocyte destruction begins with oxidative stress that causes melanocytes to release distress signals, which activate CD8 cytotoxic T cells. These immune cells attack and destroy pigment-producing melanocytes via interferon-driven JAK/STAT signaling.
How does the IFN JAK/STAT pathway contribute to vitiligo?
The IFN JAK/STAT pathway acts as a master switch in vitiligo by sustaining the immune response that targets and kills melanocytes, perpetuating skin depigmentation.
Are there treatments targeting vitiligo’s mechanism of action?
Yes. JAK inhibitors like topical ruxolitinib block the IFN JAK/STAT signaling cascade, reducing immune-mediated melanocyte death and promoting repigmentation. Phototherapy and calcineurin inhibitors modulate immune activity and oxidative stress as well.
Is vitiligo hereditary or caused by environment?
Vitiligo results from a combination of genetic susceptibility and environmental triggers such as UV exposure and skin injury that cause oxidative stress, leading to an autoimmune attack on melanocytes.
Can lifestyle changes influence vitiligo progression?
Antioxidant-rich diets, sun protection, and stress reduction can help lower oxidative stress and inflammation, supporting treatments that target the underlying vitiligo mechanism.
